Login
$CLEV
$0.67 -$0.03 (4.29%) Close

Balance Sheets

In USD, except per-share amounts
Q3 FY2026
As of Apr 30, 2026
Q2 FY2026
As of Jan 31, 2026
Q1 FY2026
As of Oct 31, 2025
Q4 FY2025
As of Jul 31, 2025
Q3 FY2025
As of Apr 30, 2025
Q2 FY2025
As of Jan 31, 2025
Q1 FY2025
As of Oct 31, 2024
Q4 FY2024
As of Jul 31, 2024
Q3 FY2024
As of Apr 30, 2024
Q2 FY2024
As of Jan 31, 2024
Q1 FY2024
As of Oct 31, 2023
Q4 FY2023
As of Jul 31, 2023
Q3 FY2023
As of Apr 30, 2023
Q2 FY2023
As of Jan 31, 2023
Q1 FY2023
As of Oct 31, 2022
Q4 FY2022
As of Jul 31, 2022
Q3 FY2022
As of Apr 30, 2022
Q2 FY2022
As of Jan 31, 2022
Q1 FY2022
As of Oct 31, 2021
Q4 FY2021
As of Jul 31, 2021
Cash
Accounts receivable
Inventory
Prepaid expenses
Total Current Assets
Property, Plant and Equipment
Equipment
Less: Accumulated depreciation
Total Property, Plant and Equipment, net
Total Assets
Current Liabilities
Accounts payable and accrued expenses
Accrued interest - stockholders
Advances - stockholders
Advances - related party
Notes payable - stockholders
Total Current Liabilities
Stockholders' Deficit
Common stock (par value $0.001) 100,000,000 shares authorized: 14,027,834 shares issued and outstanding
Additional paid-in capital
Accumulated deficit
Total Stockholders' Deficit
Total Liabilities and Stockholders' Deficit

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support